These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 1455397

  • 1. Fibrinolytic potential and antiphospholipid antibodies in systemic lupus erythematosus and other connective tissue disorders.
    Jurado M, Páramo JA, Gutierrez-Pimentel M, Rocha E.
    Thromb Haemost; 1992 Nov 10; 68(5):516-20. PubMed ID: 1455397
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
    Ihnken K, Speiser W, Müller-Berghaus G, Beyersdorf F, Schlepper M, Satter P.
    Helv Chir Acta; 1992 Jan 10; 58(4):503-8. PubMed ID: 1582860
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
    Kwieciński J, Kłak M, Trysberg E, Blennow K, Tarkowski A, Jin T.
    Arthritis Rheum; 2009 Jul 10; 60(7):2094-101. PubMed ID: 19565516
    [Abstract] [Full Text] [Related]

  • 7. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.
    Nikfardjam M, Graf S, Beckmann R, Hornykewycz S, Koller-Strametz J, Binder BR, Huber K.
    Thromb Haemost; 1999 Sep 10; 82 Suppl 1():80-4. PubMed ID: 10695493
    [Abstract] [Full Text] [Related]

  • 8. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
    Sultan Y, Harris A, Strauch G, Venot A, De Lauture D.
    J Lab Clin Med; 1988 Jun 10; 111(6):645-53. PubMed ID: 3131470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis.
    Kamper EF, Kopeikina LT, Koutsoukos V, Stavridis J.
    J Rheumatol; 1997 Feb 10; 24(2):262-8. PubMed ID: 9034981
    [Abstract] [Full Text] [Related]

  • 11. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM.
    Thromb Haemost; 1998 Dec 10; 80(6):956-60. PubMed ID: 9869167
    [Abstract] [Full Text] [Related]

  • 12. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D, Kremplewska-Nalezyta E, Gadomska G, Zastawna E, Michalski A, Drewniak W.
    Med Sci Monit; 2000 Dec 10; 6(4):684-91. PubMed ID: 11208392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Incidence of selected antiphospholipid antibodies in a group of patients with systemic lupus erythematosus].
    Fojtík Z, Beránek M, Klabusay M, Korístek Z, Buliková A.
    Vnitr Lek; 2004 Apr 10; 50(4):267-73. PubMed ID: 15214295
    [Abstract] [Full Text] [Related]

  • 15. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M, Mavri A.
    Thromb Haemost; 1995 Mar 10; 73(3):453-7. PubMed ID: 7667828
    [Abstract] [Full Text] [Related]

  • 16. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA, Gálvez MM, Cornudella R, Angós JA, Romero MS, Gutiérrez M.
    Sangre (Barc); 1994 Apr 10; 39(2):111-6. PubMed ID: 8059288
    [Abstract] [Full Text] [Related]

  • 17. In vitro clot lysis as a potential indicator of thrombus resistance to fibrinolysis--study in healthy subjects and correlation with blood fibrinolytic parameters.
    Colucci M, Scopece S, Gelato AV, Dimonte D, Semeraro N.
    Thromb Haemost; 1997 Apr 10; 77(4):725-9. PubMed ID: 9134650
    [Abstract] [Full Text] [Related]

  • 18. Fibrinolytic activity in peripheral atherosclerosis in the elderly.
    van der Bom JG, Bots ML, Haverkate F, Meyer P, Hofman A, Grobbee DE, Kluft C.
    Thromb Haemost; 1999 Feb 10; 81(2):275-80. PubMed ID: 10064006
    [Abstract] [Full Text] [Related]

  • 19. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.
    Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090
    [Abstract] [Full Text] [Related]

  • 20. Plasminogen activator inhibitor-1 is associated with impaired endothelial function in women with systemic lupus erythematosus.
    Somers EC, Marder W, Kaplan MJ, Brook RD, McCune WJ.
    Ann N Y Acad Sci; 2005 Jun 30; 1051():271-80. PubMed ID: 16126968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.